Core Laboratories Inc. (CLB) stock
CLBNYSEOil & Gas Field Services, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 11/3011% above fair value
$9.01−0.03 (-0.33%)
Close on Nov 12, 2026Market cap $412.87MP/E 26.5Yield 0.44%
Core Laboratories operating margin
Operating margin is operating income as a percentage of revenue.
Core Laboratories's operating margin for the twelve months ending Sep 30, 2026 was 7.5%. For fiscal 2025 it was 10.7%, against 11.2% the year before. The highest annual figure on record is 11.2% in fiscal 2024.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 10.7% | −0.5 |
| FY2024 | Dec 31, 2024 | 11.2% | +0.5 |
| FY2023 | Dec 31, 2023 | 10.7% | +2.2 |
| FY2022 | Dec 31, 2022 | 8.5% | −1.1 |
| FY2021 | Dec 31, 2021 | 9.6% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 9.1% | −6.4 |
| Q2 FY2026 | Jun 30, 2026 | 7.3% | −4.4 |
| Q1 FY2026 | Mar 31, 2026 | 1.5% | −2.0 |
| Q4 FY2025 | Dec 31, 2025 | 11.5% | +0.5 |
| Q3 FY2025 | Sep 30, 2025 | 15.6% | +0.8 |
| Q2 FY2025 | Jun 30, 2025 | 11.7% | −0.5 |
| Q1 FY2025 | Mar 31, 2025 | 3.6% | −3.0 |
| Q4 FY2024 | Dec 31, 2024 | 11.0% | −0.4 |
| Q3 FY2024 | Sep 30, 2024 | 14.7% | +3.0 |
| Q2 FY2024 | Jun 30, 2024 | 12.3% | −2.5 |
| Q1 FY2024 | Mar 31, 2024 | 6.6% | +1.6 |
| Q4 FY2023 | Dec 31, 2023 | 11.4% | −0.9 |
| Q3 FY2023 | Sep 30, 2023 | 11.7% | +0.1 |
| Q2 FY2023 | Jun 30, 2023 | 14.8% | +5.1 |
| Q1 FY2023 | Mar 31, 2023 | 5.0% | – |
| Q4 FY2022 | Dec 31, 2022 | 12.2% | – |
| Q3 FY2022 | Sep 30, 2022 | 11.6% | – |
| Q2 FY2022 | Jun 30, 2022 | 9.6% | – |
See a number that looks wrong?